Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study

BACKGROUND: Multiple myeloma (MM) is associated with a high risk of thrombosis, particularly during the first months of treatment including immunomodulatory drugs (IMiDs). There is no consensus on prevention of thromboembolic risk in patients with de novo MM, and identification of patients requiring...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Pract Thromb Haemost
Autors principals: Chalayer, Emilie, Tardy‐Poncet, Brigitte, Karlin, Lionel, Chapelle, Céline, Montmartin, Aurélie, Piot, Michèle, Guyotat, Denis, Collet, Philippe, Lecompte, Thomas, Tardy, Bernard
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles: Thrombosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332829/
https://ncbi.nlm.nih.gov/pubmed/30656281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12161
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars